A 28-year-old pregnant woman at 16 weeks gestation is scheduled for amniocentesis due to a family history of genetic disorders. Which nursing action is the highest priority to ensure patient safety during the procedure?
1Administer prophylactic antibiotics as prescribed
2Continuously monitor fetal heart rate during and after the procedure✓ 정답
3Position the client in a left lateral recumbent position
4Obtain signed informed consent from the client
해설
Continuous fetal heart rate monitoring is the highest priority during amniocentesis to immediately detect fetal distress from potential complications like trauma or bleeding. Other actions (antibiotics, positioning, consent) are important but less urgent for real-time safety.
Amniocentesis is an invasive prenatal diagnostic procedure typically performed between 15 and 20 weeks of gestation. A needle is inserted through the maternal abdominal wall into the amniotic sac to obtain a sample of amniotic fluid for genetic analysis. While generally safe, the procedure carries risks, most notably fetal harm from needle trauma, infection, or disruption of the fetoplacental unit. When prioritizing nursing actions, the NCLEX-RN framework demands immediate attention to physiological integrity and the reduction of direct procedural risk.
Why Continuous Fetal Heart Rate Monitoring is the Priority
The highest priority during and immediately after an amniocentesis is the assessment of fetal well-being. The primary acute complications that can occur during the procedure include direct needle injury to the fetus, umbilical cord puncture, or placental hemorrhage, all of which can manifest as abrupt changes in the fetal heart rate (FHR) pattern. Continuous monitoring allows the clinical team to detect fetal bradycardia, tachycardia, or late decelerations in real time. A sudden, sustained bradycardia could indicate a vasovagal response, cord trauma, or severe fetal distress necessitating immediate intervention, including possible emergency delivery if the gestational age is viable. This aligns with the NCLEX safety principle of directly monitoring for the most life-threatening procedural complication.
Analysis of Other Options
- Option 1: Administer prophylactic antibiotics as prescribed. Routine antibiotic prophylaxis is not the standard of care for amniocentesis. The procedure is performed under sterile conditions, and the risk of infection is low. Administering medication is also a dependent nursing action that follows a provider's order; it does not take priority over an independent, direct safety assessment.
- Option 3: Position the client in a left lateral recumbent position. While a left lateral tilt can be used to prevent supine hypotension syndrome during pregnancy, it is not the mandatory or highest-priority position for the procedure itself. Amniocentesis is typically performed with the patient in a supine position to provide a stable abdominal wall for needle insertion. A wedge may be placed under the right hip to displace the uterus, but this is a comfort and maternal hemodynamic measure, not the primary safety action for preventing fetal injury during the puncture.
- Option 4: Obtain signed informed consent from the client. Informed consent is a critical legal and ethical prerequisite for any invasive procedure. However, the question asks for the nursing action that ensures safety during the procedure. Consent must be verified before the procedure begins. Once the procedure is in progress, the nurse's priority shifts from legal documentation to physiological monitoring and immediate complication detection.
Clinical Integration and Immunological Considerations
While the provided evidence focuses on Rh immune globulin (RhIG) administration, it highlights a key post-procedural safety concern: fetomaternal hemorrhage (FMH). The scoping review by Tapley et al. addresses the risk of RhD alloimmunization after invasive events like amniocentesis . The needle puncture can cause a transplacental bleed, mixing fetal and maternal blood. In an Rh-negative mother carrying an Rh-positive fetus, this can trigger maternal sensitization. The clinical link to the correct answer is that the volume of any FMH is often estimated by the degree of FHR abnormality or by direct ultrasound visualization of bleeding. Continuous FHR monitoring serves as the immediate, real-time indicator of whether a significant hemodynamically compromising bleed or direct fetal insult has occurred, which would then dictate the urgency of further interventions, including the potential need for a Kleihauer-Betke test to quantify FMH and guide RhIG dosing . The nurse's vigilant assessment during the procedure provides the data that drives these secondary, post-procedural safety steps.
Clinical Safety Protocol
The primary safety measure during amniocentesis is real-time ultrasound guidance combined with continuous fetal heart rate (FHR) monitoring. FHR should be assessed and documented immediately before the needle insertion to establish a baseline, observed continuously on the monitor during the procedure, and reassessed immediately after needle withdrawal. Any abrupt change in rate or pattern, particularly sustained bradycardia below 110 bpm, requires immediate cessation of the procedure and physician notification.
Nursing Priority Rationale
Continuous monitoring directly addresses the most serious acute procedural risks: direct fetal needle trauma, umbilical cord laceration, or placental hemorrhage. These events manifest instantly as abnormal FHR tracings. While informed consent must be verified and the patient positioned supine with a wedge under the right hip to prevent supine hypotension, these actions are preparatory. Monitoring is the only intervention that provides real-time physiological data to detect a life-threatening emergency as it occurs.
Post-Procedure Surveillance
Monitoring continues after the procedure. FHR and uterine activity are assessed every 15 minutes for the first hour. The nurse observes for vaginal fluid leakage, bleeding, cramping, or signs of infection. Rh-negative patients must receive Rh immune globulin (RhoGAM) within 72 hours to prevent isoimmunization if the fetus is Rh-positive. Discharge teaching includes instructions to report fever, chills, fluid leakage, or decreased fetal movement.
Amniocentesis — An invasive prenatal diagnostic procedure performed between 15 and 20 weeks gestation where a needle is inserted through the maternal abdomen into the amniotic sac to obtain amniotic fluid for genetic analysis.
Fetal Bradycardia — A sustained fetal heart rate below 110 beats per minute, which during amniocentesis could indicate a vasovagal response, umbilical cord trauma, or severe fetal distress requiring immediate intervention.
Placental Hemorrhage — Bleeding originating from the placenta, a potential acute complication of amniocentesis caused by needle puncture, which can compromise fetal oxygenation and manifest as abnormal heart rate patterns.